Nylia 1/35 Kit
Product Images NDC 65862-898

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nylia 1/35 (NDC 65862-898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Norethindroneethinyl Fig1)

The text describes a figure depicting circulatory disease mortality rates by age, smoking status and oral contraceptive use. The figure shows mortality rates per 100,000 women-years and includes groups of smokers and non-smokers who have ever used oral contraceptives and controls who have not. The mortality rates vary by age group, with higher rates for older women. The source reference of the figure is mentioned.*

FDA Label Image

Elliona Figure 2 (Norethindroneethinyl Fig2)

This text provides a list of studies conducted on women's use of contraceptives, including their current or past use, and the associated effect estimate. The studies mentioned are the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study I, xord Family Planning Association Study, The Nurses' Health Study II, and Danish Sex Hormone Register Study. The effect estimate (OR/RR) is given for each study, and some of them include the years the studies were conducted. The last line of numbers is not clear and its purpose is not evident.*

FDA Label Image

Elliona Figure 3 (Norethindroneethinyl Fig3)

FDA Label Image

Elliona Figure 4 (Norethindroneethinyl Fig4)

This is a label template for selecting the correct day of the week. There is an example image with encrypted text in it. The last line refers to a medication named Nylia containing 1 mg of Norethindrone and 0.035 mg of Ethinyl Estradiol in tablet form.*

FDA Label Image

Elliona Figure 5 (Norethindroneethinyl Fig5)

FDA Label Image

Elliona Figure 6 (Norethindroneethinyl Fig6)

FDA Label Image

Package Label-principal Display Panel – 1 mg/0.035 mg Pouch Label (Norethindroneethinyl Fig7)

FDA Label Image

Package Label-principal Display Panel – 1 mg/0.035 mg Pouch Carton (Norethindroneethinyl Fig8)

FDA Label Image

Norethindroneethinyl Fig9

This is a product description for Nylia™ 1/35 which is a combined oral contraceptive containing Norethindrone and Ethinyl Estradiol Tablets, USP. It is intended for the prevention of pregnancy but does not protect against sexually transmitted diseases. The usual dosage is one tablet daily as prescribed, and the product comes with six pouches with each containing 28 tablets. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. It is important to keep it out of reach of children. The text also includes information about the contents of each tablet and storage conditions.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str)

Norethindrone Ethinyl estradiol is a pharmaceutical product composed of chemicals OH, CHy, CHy, C=CH, o", and HO. No further information about this substance is available from the given text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.